Trial Profile
A Prospective, Randomized, Open-Label, Active-Controlled Study in Adult Subjects With Acute Bacterial Sinusitis Comparing the Clinical Efficacy of Telithromycin (KETEK) 800 Mg Once a Day for 5 Days Versus Amoxicillin-Clavulanic Acid (AUGMENTIN) 875/125 Mg Twice a Day for 10 Days
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Telithromycin (Primary) ; Amoxicillin/clavulanic acid
- Indications Acute sinusitis; Bacterial infections
- Focus Therapeutic Use
- Acronyms CHOOSE
- 29 Sep 2009 Planned end date (Dec 2005) added as reported by ClinicalTrials.gov.
- 19 Nov 2005 New trial record.